Safety and Immunogenicity of SIIPL Tdap, a New Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, in Healthy Subjects 4–65 Years of Age: A Phase II/III Randomized, Observer-Blinded, Active Controlled, Multicenter Clinical Study in Germany
Vaccine（2023）
Key words
Acellular pertussis,Booster,Tetanus,Diphtheria,Vaccine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined